Basics RenovoRx, Inc. IPO Date: August 26, 2021 Sector: Healthcare Industry: Biotech Market Cap: $43.98M Activated in VL: True Average Daily Range Avg Daily Range: $0.12 | 4.67% Avg Daily Range (30 D): $0.05 | 4.28% Avg Daily Range (90 D): $0.04 | 3.32% Institutional Daily Volume Avg Daily Volume: .3M Avg Daily Volume (30 D): .69M Avg Daily Volume (90 D): .36M Trade Size Avg Trade Size (Sh.): 173 Avg Trade Size (Sh.) (30 D): 413 Avg Trade Size (Sh.) (90 D): 418 Institutional Trades Total Inst.Trades: 8 Avg Inst. Trade: $1.13M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .1M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: K     News Jun 26, 2024 @ 12:30 PM University of Nebraska Medical Center Launches Pat... Source: RenovoRx, Inc. Jun 10, 2024 @ 12:30 PM RenovoRx Appoints Ryan Witt as Senior Vice Preside... Source: RenovoRx, Inc. Jan 2, 2024 @ 6:35 PM Why Longboard Pharmaceuticals Shares Are Trading H... Source: Avi Kapoor Dec 28, 2023 @ 6:07 PM Why DouYu International Shares Are Trading Higher ... Source: Avi Kapoor Jun 30, 2023 @ 10:00 AM What to Look for in a Penny Stocks Trading Platfor... Source: D. Marie Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.38 $-.08 $-.08 Diluted EPS $-.38 $-.08 $-.08 Revenue $ .42M $ .27M $ .1M Gross Profit $ $ $ Net Income / Loss $ -10.66M $ -2.9M $ -2.42M Operating Income / Loss $ -11.25M $ -2.68M $ -3.11M Cost of Revenue $ $ $ Net Cash Flow $ 5.98M $ M $ M PE Ratio